U.S. Renewable Energy Stock News

TransUnion (TRU) recently expanded its TruIQ Data Enrichment offering on the Snowflake AI Data Cloud to support prescreen credit marketing campaigns, allowing Snowflake users to work directly with TransUnion credit data. See our latest analysis for TransUnion. Despite the TruIQ expansion on Snowflake, which points to deeper use of its credit data in digital marketing and analytics, TransUnion’s recent momentum has been soft, with the share price down 15.2% year to date and the 1 year total...

Devon Energy (DVN) has been drawing fresh attention after recent share price moves, with the stock down 3.7% on the day and modestly weaker over the past month and the past 3 months. See our latest analysis for Devon Energy. At the current share price of $44.28, Devon Energy’s recent 1-day share price decline of 3.72% and softer 30-day return of 2.92% contrast with a stronger year to date share price return of 16.93% and a 1-year total shareholder return of 40.68%. This suggests that shorter...

Earnings beat and bond exchange put Skyworks Solutions (SWKS) in focus Skyworks Solutions (SWKS) has drawn fresh attention after reporting fiscal Q2 earnings that surpassed analyst expectations, alongside a fixed income exchange offer involving its 2029 and 2031 senior notes. The quarter was supported by WiFi, data center, and automotive markets, with management pointing to lean channel inventories, solid demand, and a multi generational design win that is expected to contribute through...

Warner Music Group recently faced a lawsuit from the American Federation of Musicians, which claims the company licensed sound recordings for AI training without properly compensating or informing union musicians about how their work was used. Beyond potential financial exposure, the dispute highlights how Warner Music’s push into AI-related licensing could test its relationships with artists and unions at a time when control over music data is increasingly sensitive. Next, we’ll examine how...

Acadia Healthcare Company (ACHC) is back in focus after a strong first quarter, with Raymond James upgrading the stock and the company modestly lifting its 2026 earnings and EBITDA guidance. See our latest analysis for Acadia Healthcare Company. Despite a 2.9% decline in the 1 day share price return to US$24.48, Acadia’s strong first quarter update and higher 2026 guidance sit alongside a 71.31% year to date share price return and a weaker 3 year total shareholder return. This suggests recent...

Nasdaq (NDAQ) has come under pressure recently, with the stock down 1.3% on the day and lower over the past week and month, despite no fresh company specific news driving the move. See our latest analysis for Nasdaq. The weak 7-day share price return of 5.66% and year-to-date share price decline of 9.7% contrast with a 1-year total shareholder return of 3.19% and 5-year total shareholder return of 61.5%. This suggests that shorter term momentum has cooled, while longer term holders have still...

ACM Research (ACMR) dropped 9.4% during a broad selloff in semiconductor equipment stocks, as concerns about the sector’s near term outlook combined with fresh downward revisions to the company’s earnings estimates. See our latest analysis for ACM Research. The latest drop comes after a strong run, with the share price up 27.47% over 30 days and 63.40% over 90 days, while the 1-year total shareholder return is very large and the 3-year total shareholder return is more than 6x. This suggests...

Mueller Water Products (MWA) moved into focus after fiscal first-quarter results came in ahead of expectations and management raised guidance, supported by resilient demand, margin benefits from a new brass foundry, and increased institutional attention. See our latest analysis for Mueller Water Products. At a share price of US$25.33, Mueller Water Products has seen short term share price pressure, with a 30 day share price return down 3.94% and a 90 day share price return down 9.5%. Its 3...

TFS Financial (TFSL) has caught investor attention after recent stock moves, with the share price at $16.42 and a trailing 1 year total return of 34.26% prompting a closer look at fundamentals. See our latest analysis for TFS Financial. The recent 1 month share price return of 8.74% and 3 month share price return of 18.39% suggest momentum has been building, while the 1 year total shareholder return of 34.26% sits alongside a 3 year total shareholder return of 62.56%. Together, these figures...

Broadcom (AVGO) is back in focus after its latest quarter, where record AI chip revenue and strong guidance sat alongside a sharp share-price pullback as investors reassessed lofty expectations for the stock. See our latest analysis for Broadcom. The recent pullback has been sharp, with the share price down 7.92% over the last day and 13.66% over the week. However, the 1 year total shareholder return of 57.48% and very large 5 year total shareholder return indicate a powerful longer term...

In early June 2026, USA Compression Partners, LP presented at Bank of America’s Energy & Power Credit Conference and RBC Capital Markets’ Global Energy, Power & Infrastructure Conference in New York, following first-quarter 2026 results that exceeded revenue expectations and reaffirmed full-year guidance. A key insight from these updates is how the J-W Power acquisition and tight compression market are supporting USA Compression’s utilization and contract visibility. Next, we’ll examine...

Starbucks recently reported March-quarter 2026 results with adjusted earnings per share of US$0.50 on revenue of US$9.50 billion, while advancing its “Back to Starbucks” plan to revitalize stores and broaden revenue streams through licensing and Channel Development. In parallel, the company has begun tying a portion of most tech employees’ bonuses to AI usage and is seeing increased afternoon and evening U.S. store traffic, underscoring its push to blend technology with evolving customer...

Alexandria Real Estate Equities, Inc. previously declared a quarterly cash dividend of US$0.72 per common share for the March 2026 quarter, payable on July 15, 2026 to shareholders of record as of June 30, 2026. This dividend affirmation comes as the company faces concerns over weakened financial strength, debt pressures, and softer leasing and occupancy trends that raise questions about its operational resilience. We’ll now examine how heightened debt and financial distress concerns could...

Vaxcyte (PCVX) has dosed the first participant in its Phase 1 trial of VAX-A1, a Group A Strep vaccine candidate. This is a key early step in testing a product aimed at a large unmet medical need. See our latest analysis for Vaxcyte. Despite the positive development for VAX-A1, recent share price momentum has been soft, with the stock down 10.66% on a 30 day share price return and 20.16% on a 90 day share price return, while the 1 year total shareholder return of 28.03% and 5 year total...

Willis Towers Watson (WTW) has drawn fresh attention after its Dubai unit secured a DFSA licence to operate in the Dubai International Financial Centre, broadening access to regulated investment advisory and fund solutions across the Middle East. See our latest analysis for Willis Towers Watson. Alongside the DFSA approval, WTW has rolled out an AI Workforce Transformation solution, added new UK employee benefits partnerships and refreshed its North American cyber leadership team. Yet despite...

Ocular Therapeutix stock moves Ocular Therapeutix (OCUL) has been drawing attention after a stretch of weak share performance, with the stock down 6.3% on the day and declining over the past week, month, and past 3 months. See our latest analysis for Ocular Therapeutix. That weak one day share price move sits on top of a fading trend, with the 30 day share price return down 14.51%, the year to date share price return down 30.20%, and the 1 year total shareholder return down 8.54%, even though...

RenaissanceRe Holdings (RNR) is back on investor radars after recent share price swings, with the stock up 3.9% over the past day but down over the past month and the past 3 months. See our latest analysis for RenaissanceRe Holdings. Zooming out, RenaissanceRe’s recent 1-day share price gain of 3.87% to $288.48 contrasts with a weaker 30-day share price return of 3.89% and a year-to-date gain of 5.97%. At the same time, the 1-year total shareholder return of 17.59% and 5-year total...

In its recent quarterly report, 1st Source Corp. posted higher profit, raised its dividend, and increased loan loss reserves to address ongoing economic uncertainty and credit risks. An important takeaway is management’s emphasis on safety and soundness, with a proactive reserve build that may reassure investors about risk management discipline. We will now explore how the profit growth and higher dividend shape 1st Source’s broader investment narrative for current and prospective...

Earlier this week, Cardinal Health reported Q3 fiscal 2026 results that exceeded estimates and raised its full-year adjusted EPS and free cash flow guidance, alongside updates on theranostics expansion and a voluntary recall of certain alcohol prep pads. The combination of upgraded outlook and continued investment in its Center for Theranostics Advancement highlighted management’s confidence in Cardinal Health’s higher-value growth initiatives, even as the company managed operational and...

Snap (SNAP) continues to draw attention after recent trading left the stock at US$5.76, with mixed short term returns and an ongoing loss position shaping how investors assess its risk and potential reward. See our latest analysis for Snap. Recent trading has been choppy, with the 1 day share price return down 5.11% and the 30 day share price return down 5.26%. A 90 day share price return of 12.28% suggests that momentum has cooled after a stronger spring, set against a 1 year total...

In May 2026, PROCEPT BioRobotics reported two milestones in its WATER IV prostate cancer program: full enrollment of the 280‑patient randomized trial comparing Aquablation therapy with radical prostatectomy, and FDA IDE approval for a second global randomized study comparing Aquablation with active surveillance. By positioning Aquablation against both the surgical standard of care and active surveillance, PROCEPT is testing whether its robotic waterjet approach can expand treatment options...

China Yuchai International (CYD) has drawn fresh investor attention after its recent share performance, with the stock up about 23% over the past month and roughly 37% in the past 3 months. See our latest analysis for China Yuchai International. Zooming out, the 22.75% 1 month share price return and 53.32% year to date share price return sit alongside a very large 1 year total shareholder return. Momentum remains positive despite a small 1 day pullback of 2.41%. If this move has you thinking...

In early June 2026, RadNet, Inc. moved to secure a US$200 million incremental term loan maturing in 2031 to help fund acquisitions, organic expansion, health system partnerships, and other corporate purposes across its imaging network and technology platforms. This fresh borrowing push comes shortly after RadNet reported strong revenue growth but weaker-than-expected earnings, highlighting management’s focus on expansion and technology investment despite recent profit pressure. We’ll now...

Kimberly-Clark (KMB) is back in focus after stronger-than-expected earnings, reaffirmed guidance, an outlook update at a major consumer conference, and regulatory clearance for a planned international portfolio sale. See our latest analysis for Kimberly-Clark. The recent earnings beat, upbeat guidance and progress on the international portfolio sale helped lift Kimberly-Clark’s 1-day share price return by 4.84% to US$99.04, even though the 1-year total shareholder return is down 22.21%. This...